These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 7931040

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.
    Stalenhoef AF, de Graaf J, Wittekoek ME, Bredie SJ, Demacker PN, Kastelein JJ.
    Atherosclerosis; 2000 Nov; 153(1):129-38. PubMed ID: 11058707
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Gemfibrozil, nicotinic acid and combination therapy in patients with isolated hypoalphalipoproteinemia: a randomized, open-label, crossover study.
    Zema MJ.
    J Am Coll Cardiol; 2000 Mar 01; 35(3):640-6. PubMed ID: 10716466
    [Abstract] [Full Text] [Related]

  • 30. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability.
    Bredie SJ, de Bruin TW, Demacker PN, Kastelein JJ, Stalenhoef AF.
    Am J Cardiol; 1995 Feb 15; 75(5):348-53. PubMed ID: 7856526
    [Abstract] [Full Text] [Related]

  • 31. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
    Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V.
    N Engl J Med; 1987 Nov 12; 317(20):1237-45. PubMed ID: 3313041
    [Abstract] [Full Text] [Related]

  • 32. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ, Brun D, Gagné C, Moorjani S, Bielman P, Julien P.
    Can J Cardiol; 1991 Nov 12; 7(1):27-33. PubMed ID: 2025787
    [Abstract] [Full Text] [Related]

  • 33. The hypolipidemic effects of gemfibrozil in type V hyperlipidemia. A double-blind, crossover study.
    Leaf DA, Connor WE, Illingworth DR, Bacon SP, Sexton G.
    JAMA; 1989 Dec 08; 262(22):3154-60. PubMed ID: 2681858
    [Abstract] [Full Text] [Related]

  • 34. The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia.
    Feussner G, Eichinger M, Ziegler R.
    Clin Investig; 1992 Nov 08; 70(11):1027-35. PubMed ID: 1472833
    [Abstract] [Full Text] [Related]

  • 35. Fenofibrate of gemfibrozil for treatment of types IIa and IIb primary hyperlipoproteinemia: a randomized, double-blind, crossover study.
    Insua A, Massari F, Rodríguez Moncalvo JJ, Rubén Zanchetta J, Insua AM.
    Endocr Pract; 2002 Nov 08; 8(2):96-101. PubMed ID: 11942772
    [Abstract] [Full Text] [Related]

  • 36. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A.
    Adv Perit Dial; 1996 Nov 08; 12():261-5. PubMed ID: 8865916
    [Abstract] [Full Text] [Related]

  • 37. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
    Samuelsson O, Attman PO, Knight-Gibson C, Kron B, Larsson R, Mulec H, Weiss L, Alaupovic P.
    Nephron; 1997 Nov 08; 75(3):286-94. PubMed ID: 9069450
    [Abstract] [Full Text] [Related]

  • 38. Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia.
    Wiklund O, Angelin B, Bergman M, Berglund L, Bondjers G, Carlsson A, Lindén T, Miettinen T, Odman B, Olofsson SO.
    Am J Med; 1993 Jan 08; 94(1):13-20. PubMed ID: 8420296
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.